COMMUNIQUÉS West-GlobeNewswire

-
Interim Report Q2 2025: Commercial and operational agility drove market share gains and 46% EBITA growth
21/08/2025 -
Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants
21/08/2025 -
Latest breakthrough in Type 1 diabetes treatment: Chinese medical team enables 24 patients to discontinue insulin use
21/08/2025 -
Telix 2025 Half-Year Results: Strong commercial performance enables investment for long-term growth
21/08/2025 -
Ascentage Pharma Reports 2025 Interim Unaudited Six Months Financial Results and Business Updates
21/08/2025 -
Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting
20/08/2025 -
BioAge Labs to Present at Upcoming Investor Conferences
20/08/2025 -
Onco360® Has Been Selected as a Specialty Pharmacy Partner for HERNEXEOS® (zongertinib)
20/08/2025 -
Olema Oncology to Participate in Upcoming Investor Conferences
20/08/2025 -
Outset Medical to Present at the 23rd Annual Morgan Stanley Global Healthcare Conference
20/08/2025 -
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
20/08/2025 -
NurExone Biologic Announces Preclinical Evidence of Structural Repair in Injured Spinal Cord Tissue following ExoPTEN Treatment
20/08/2025 -
Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity
20/08/2025 -
Invivyd Announces Proposed Public Offering of Common Stock
20/08/2025 -
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
20/08/2025 -
APIX Biosciences NV announces new advances in Honeybee Nutrition
20/08/2025 -
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement
20/08/2025 -
King Faisal Specialist Hospital Provides Nearly 300,000 Virtual Consultations in 2024
20/08/2025 -
OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer
20/08/2025
Pages